Skip to main content
Clinical Trials/NCT05947630
NCT05947630
Completed
Not Applicable

IMPression 3D & ACcès à la Teléréadaptation / 3D-printen en Toegang Tot Telerevalidatie

Lieven De Maesschalck4 sites in 3 countries79 target enrollmentMay 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Orthopedic Disorder
Sponsor
Lieven De Maesschalck
Enrollment
79
Locations
4
Primary Endpoint
Ankle angle test
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study will investigate whether 3D printing of orthoses (night splints and AFO/KAFO for walking, further named as dynamic AFO/KAFO) for the lower limbs can help to improve the limited accessibility to orthopaedic devices in developing countries. The 3D printed orthoses will be assessed for effectiveness, cost and feasibility. Measurement and manufacture of the orthoses is also supported remotely via video conferencing.

Detailed Description

Specifically, the study is being conducted in 3 West African countries: Togo, Niger and Mali. A total of 4 orthopaedic centres are involved, whereby an equal number of patients are recruited everywhere. There are 2 groups of patients, those who need a (knee) ankle-foot orthosis to move around (dynamic AFO/KAFO) and those who need a night splint to correct the ankle or knee position. All patients in the study will have a treatment route involving fitting a new traditional orthosis and a new 3D printed orthosis. The order of application of both treatments will be randomised in a crossover design. Patients will be measured at baseline after the first treatment period (3 weeks) and after the second treatment period (6 weeks). The primary outcome measures are different for both groups of patients: the walking speed when performing the 10-metre walk test in the patients wearing the dynamic AFO/KAFO, and the measured angle (of knee or ankle) in the patients wearing a night splint.

Registry
clinicaltrials.gov
Start Date
May 15, 2018
End Date
April 15, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Lieven De Maesschalck
Responsible Party
Sponsor Investigator
Principal Investigator

Lieven De Maesschalck

Innovation Manager

Thomas More Kempen

Eligibility Criteria

Inclusion Criteria

  • Pathology: foot stance abnormality
  • Both unilateral and bilateral orthoses are included
  • Pathology: genu varum

Exclusion Criteria

  • Patient is already wearing a night splint
  • The patient cannot stand upright
  • The patient is pregnant

Outcomes

Primary Outcomes

Ankle angle test

Time Frame: 5 weeks

Ankle angle test

10 meter walk test

Time Frame: 5 weeks

10 meter walk test

knee angle test

Time Frame: 5 weeks

Knee angle test

Secondary Outcomes

  • Range of motion(5 weeks)
  • OPUS questionnnaire(5 weeks)

Study Sites (4)

Loading locations...

Similar Trials